Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis
β Scribed by Ismail Oguz Kara; Berksoy Sahin; Ramazan Gunesacar
- Publisher
- Springer Healthcare Communications
- Year
- 2007
- Tongue
- English
- Weight
- 248 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0741-238X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-C
Background: Programmed cell death (PCD) is characterized by a sequence of tightly regulated events that result in the activation of caspases and in internucleosomal DNA cleavage. Late apoptotic events such as DNA-strand breaks can be assayed by in situ end labeling (ISEL) and DNA measurement (sub G1
## Abstract Bβcell chronic lymphocytic leukemia (CLL) is characterized by a high rate of clonal genomic alterations and a low proliferative activity with cell cycle arrest in G~0~/G~1~ phase. Recently, centrosome aberrations have been described as a possible cause of chromosomal instability and ane